The contaminated products, distributed exclusively to physician offices, may increase the risk for infection, skin irritation, or delayed wound healing.

Despite the initiation of a phase 3 confirmatory trial, the FDA remains unsatisfied with the interpretability of phase 2 data for Replimune’s oncolytic immunotherapy.

For men with locally advanced prostate cancer, transdermal estradiol (tE2) patches are noninferior to luteinizing ...

Risk for heart attack or stroke was halved with current season flu vaccine. HealthDay News — Influenza vaccination may offer cardiovascular protection even when it does not prevent infection, ...

A political appointee at CDC would be very rarely involved in a review or decision regarding MMWR,” said Dr Debra Houry who ...

Growing demand for estrogen patches to relieve menopause symptoms has led to shortages, leaving women searching multiple pharmacies or switching medications. Ex ...

Access to the pill has become a major issue in the wake of the 2022 US Supreme Court decision that allowed states to ban abortion. HealthDay News — US District Judge David Joseph turned down Louisiana ...